— Know what they know.
Not Investment Advice

IIN NASDAQ

IntriCon Corporation
1W: +0.9% 1M: +0.8% 3M: +44.1% 1Y: +1.1% 3Y: -2.8% 5Y: +218.9%
$24.23
Last traded 2022-05-24 — delisted
NASDAQ · Healthcare · Medical - Instruments & Supplies

Cash Flow Trends

Operating Cash Flow
$438K -92.2% ▼
Capital Expenditures
$3M +31.0% ▲
5Y CAGR: +7.2%
Free Cash Flow
-$2M -204.0% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$3M -2685.6% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2017FY2018FY2019FY2020FY2021
— Operating Activities —
Net Income$2M$6M-$4M-$3M-$106K
Depreciation & Amort.$2M$3M$3M$5M$6M
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital-$508K-$11M-$5M$259K-$7M
Other Non-Cash Items-$102K$1M$5M$877K-$610K
Operating Cash Flow$4M$177K$1M$6M$438K
— Investing Activities —
Capital Expenditures-$2M-$6M-$5M-$4M-$3M
Acquisitions (Net)-$2M-$1M-$609K-$7M$0
Investment Purchases$0-$38M-$44M-$20M-$25M
Investment Sales$0$0$50M$27M$25M
Other Investing$19K$0-$818K$0-$379K
Investing Cash Flow-$5M-$45M-$227K-$4M-$2M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0-$26M$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$103K$52M-$109K-$2M-$1M
Financing Cash Flow-$103K$52M-$109K-$2M-$1M
Net Change in Cash-$294K$7M$1M$118K-$3M
Cash End of Period$373K$8M$9M$9M$6M
Free Cash Flow$2M-$5M-$3M$2M-$2M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms